RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/16005964http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16005964http://www.w3.org/2000/01/rdf-schema#comment"CCAAT/enhancer binding proteins (C/EBPs) are a family of transcription factors that have been implicated in diverse cellular functions such as cellular differentiation and proliferation, and inflammatory processes. C/EBPzeta, also known as GADD153, CHOP10, and DDIT3 has been found associated with the development of myxoid liposarcoma and the progression of melanoma. To investigate the correlation of C/EBPzeta transcript levels with the development of leukemia, samples from 187 patients with myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) were examined for C/EBPzeta mRNA using real-time quantitative PCR (RQ-PCR). RQ-PCR analysis demonstrated the median levels of C/EBPzeta were significantly decreased in MDS, AML, and CML patients compared with normal controls (1.40, 0.96, 2.60 versus 14.69, P<0.0001). Significant differences were also observed between patients with CML and with AML or MDS. These results suggest that the insufficient dosage of C/EBPzeta might be involved in the development of leukemia."xsd:string
http://purl.uniprot.org/citations/16005964http://purl.org/dc/terms/identifier"doi:10.1016/j.leukres.2005.05.020"xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/author"Chen Z."xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/author"Lin J."xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/author"Wang W."xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/author"Qian J."xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/author"Cen J."xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/date"2005"xsd:gYear
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/name"Leuk Res"xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/pages"1435-1441"xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/title"Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases."xsd:string
http://purl.uniprot.org/citations/16005964http://purl.uniprot.org/core/volume"29"xsd:string
http://purl.uniprot.org/citations/16005964http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/16005964
http://purl.uniprot.org/citations/16005964http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/16005964
http://purl.uniprot.org/uniprot/#_P35638-mappedCitation-16005964http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16005964
http://purl.uniprot.org/uniprot/#_P0DPQ6-mappedCitation-16005964http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16005964
http://purl.uniprot.org/uniprot/#_Q53YD1-mappedCitation-16005964http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16005964
http://purl.uniprot.org/uniprot/P35638http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16005964
http://purl.uniprot.org/uniprot/Q53YD1http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16005964
http://purl.uniprot.org/uniprot/P0DPQ6http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16005964